Viatris (VTRS) EBITDA Margin (2020 - 2026)
Viatris' EBITDA Margin came in at 18.06% for Q2 2026, down 7.38 percentage points from 25.44% a year earlier but up 1.11 percentage points from the prior quarter.
Viatris (VTRS) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Viatris reported EBITDA Margin of 18.43%, up 17.33 percentage points year-over-year; for FY2025, it came in at 0.95%, down 18.75 percentage points from FY2024.
- EBITDA Margin has declined in each of the last three years, with a five-year change of -15.84 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 19.70% in FY2024 (-3.03 pp), 22.73% in FY2023 (-5.82 pp), 28.55% in FY2022 (+3.54 pp) and 25.01% in FY2021 (+8.22 pp).
- The five-year range for quarterly EBITDA Margin is -68.14% (Q1 2025) to 34.43% (Q1 2022).
- Year-over-year, EBITDA Margin increased in three of the last eight quarters, with an average year-over-year change of +0.14 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q1 2026 (a gain of 85.10 percentage points), and the weakest in Q1 2025 (a drop of 92.57 percentage points).
- Business Quant data shows VTRS's EBITDA Margin at 16.96% (Q1 2026), 15.50% (Q4 2025) and 23.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Viatris | 20.35 Bn | 15.36 Bn | 1.46 Bn | 18.06% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.06% |
| Mar 31, 2026 | 16.96% |
| Dec 31, 2025 | 15.50% |
| Sep 30, 2025 | 23.07% |
| Jun 30, 2025 | 25.44% |
| Mar 31, 2025 | -68.14% |
| Dec 31, 2024 | 16.05% |
| Sep 30, 2024 | 23.88% |
| Jun 30, 2024 | 14.39% |
| Mar 31, 2024 | 24.43% |
| Dec 31, 2023 | 4.95% |
| Sep 30, 2023 | 28.69% |
| Jun 30, 2023 | 26.95% |
| Mar 31, 2023 | 30.30% |
| Dec 31, 2022 | 17.25% |
| Sep 30, 2022 | 30.89% |
| Jun 30, 2022 | 30.87% |
| Mar 31, 2022 | 34.43% |
| Dec 31, 2021 | 15.48% |
| Sep 30, 2021 | 30.30% |
Viatris EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VTRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VTRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VTRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();